Cat.#: ACPP-1335
Despition | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide for Immunocompetition, Immunodepletion |
SIZE | 250 µg |
Applications | Immunodepletion & Immunocompetition assay |
Storage | Store at -20⁰C for long term |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1363 | Presenilin 1 Blocking Peptide (AC1363) | 250 µg | inquiry |
ACPP-1025 | Recombinant Human GPR56 Protein (6×His Tag) (AC1025) | 50 µg | inquiry |
ACPP-1319 | Axin 2 Blocking Peptide (AC1319) | 250 µg | inquiry |
ACPP-1435 | Human CHGA Protein, His (AC1435) | 2 µg | inquiry |
ACPP-1444 | Human VAMP2 Protein (AC1444) | 5 µg | inquiry |
ACPP-1726 | Human Midkine Protein (AC1726) | 5 µg | inquiry |
ACPP-1174 | Synthetic Nanodisc Human CD97 Protein (AC1174) | 10 µg | inquiry |
ACPP-1706 | Human HPCAL1 Protein (AC1706) | 2 µg | inquiry |
ACPP-1088 | Synthetic Exosome Human CD24 Protein (AC1088) | 50 µg | inquiry |
ACPP-1766 | Human HMGA2 Protein (AC1766) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.